Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus
- 7 April 1990
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 335 (8693), 854
- https://doi.org/10.1016/0140-6736(90)90966-9
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentrationBiochemical and Biophysical Research Communications, 1989
- Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes MellitusNew England Journal of Medicine, 1989
- Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.Proceedings of the National Academy of Sciences, 1988
- Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitroNature, 1988
- Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.Proceedings of the National Academy of Sciences, 1987
- Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.Proceedings of the National Academy of Sciences, 1987